Related Experiment Video
Updated: Jun 2, 2026
05:01
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
Exploratory factor analysis of pathway copy number data with an application towards the integration with gene
Wessel N van Wieringen1, Mark A van de Wiel
1Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands. w.vanwieringen@vumc.nl
Summary
This study introduces a new method using exploratory factor analysis to analyze cancer gene pathway copy number variations. The approach helps understand genomic aberrations and their impact on gene expression.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Cancer research increasingly focuses on gene pathways rather than individual genes.
- Understanding pathway regulatory mechanisms requires multi-level molecular analysis.
- Genomic copy number data presents complex variability.
Purpose of the Study:
- To develop a method for characterizing variability in cancer gene pathway copy number data.
- To explore latent variable models for pathway call probability data.
- To link genomic aberrations to gene expression patterns.
Main Methods:
- Exploratory factor analysis applied to pathway copy number data.
- Development and fitting of a latent variable model using an Expectation-Maximization (EM) algorithm.
- Analysis of two breast cancer datasets, including Gene Ontology (GO) nodes.
Main Results:
- The first two latent variables derived from GO nodes provide interpretable insights.
- Latent variables correlate with the proportion of genomic aberrations (gain/loss).
- Linking latent variables to gene expression data reveals global effects of aberrations.
Conclusions:
- The proposed method offers insightful characterization of pathway copy number data.
- This approach can elucidate interactions between DNA copy number aberrations and gene expression.
- Facilitates multi-omic studies in cancer research.
